Anquor Corporate Finance
TTR ID Profile: 149403
|
|
Company Size: 1-10
Year Founded: 2019
Website:
www.anquorcf.com
E-mail:
contact@anquorcf.com
LinkedIn: view profile
Avenida Diagonal, 361, 2º 2ª
08037
Barcelona, Cataluña, Spain
Tel.: +34 933 906 191
Other Offices (2)
Last update on: 22 Apr 2025
Main Details
Short Description
Financial Advisor.
Name
Anquor Corporate Finance
Year Founded
2019
Entity Type
Financial Advisors / Auditor
Corporate Status
Registered Name
Anquor Corporate Finance, S.L.
CIF / NIF / CNPJ / TAX ID
B88486907
Corporate Structure
Private Company
Country - State / Province / District
Spain - Cataluña
Key Executives and Professionals
| Name | Job Title | ||
|---|---|---|---|
| Pascal Vieilledent | Founder & CEO - Chief Executive Officer | pascal@anquorcf.com | vCard |
| Pauline Houl | Managing Partner | - | |
| Álvaro Bailo | Partner | alvaro.bailo@anquorcf.com | vCard |
| Antonio Bela | Partner | antonio.bela@anquorcf.com | vCard |
| Emilia Martínez | Partner | emilia.martinez@anquorcf.com | vCard |
| Gabriel Mesquida | Partner | gabriel.mesquida@anquorcf.com | vCard |
| Josep Aiguade | Partner | josep.aiguade@anquorcf.com | vCard |
| Josep María Piqueras | Partner | - | |
| Marc Cebrian | Partner | marc.cebrian@anquorcf.com | vCard |
| Patrick Sabaté | Partner | patrick.sabate@anquorcf.com | vCard |
| Pere Colomer | Partner | pere.colomer@anquorcf.com | vCard |
| Simon Lepage | Partner | simon.lepage@anquorcf.com | vCard |
| Alex Moragas | Associate | alex.moragas@anquorcf.com | vCard |
| Martí Puig Malaret | Senior Analyst | marti.puig@anquorcf.com | vCard |
| Bruno Cosano Solá | Analyst | bruno.cosano@anquorcf.com | vCard |
Mergers & Acquisitions
| Date | Target | Country | Buyer | Seller | VALUE (EURm) | Sector | |||
|---|---|---|---|---|---|---|---|---|---|
|
07 Nov 2024
Completed
|
Bebegel Business | Portugal | Theralab | Cooper Consumer Health | ND |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
|
||
|
11 Jul 2024
Completed
|
Agsa | Spain | Everwood Capital | Private Shareholders I | ND |
35.09.02 Ports 35 Industrials / 35.09 Transport Infrastructure |
|
||
|
11 Sep 2023
Completed
|
Mabo Farma | Spain | PharmaS | Private Shareholders I | ND |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
 |
|
|
|
27 Mar 2023
Completed
|
Apexfarma, Cross Pharm | Switzerland, Spain | Piex | Private Shareholders I | ND |
10.02.01 Advertising & Marketing Services 10 Business Services / 10.02 Marketing & Advertising 30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
|
||
|
13 Feb 2023
Completed
|
Natifar, Natimed | Spain | SIT Laboratorio Farmaceutico | Laboratorios BIAL | ND |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
|
|
Private Equity
| Date | Target | Country | Buyer | Seller | VALUE (EURm) | Sector | |||
|---|---|---|---|---|---|---|---|---|---|
|
11 Jul 2024
Completed
|
Agsa | Spain | Everwood Capital | Private Shareholders I | ND |
35.09.02 Ports 35 Industrials / 35.09 Transport Infrastructure |
|
||
|
12 Sep 2022
Completed
|
Vesismin Health | Spain | Schülke | Private Shareholders I | ND |
55.02.04 Pharmaceutical & Personal Care Chemicals 55 Raw Materials & Natural Resources / 55.02 Chemicals |
|
|